Veeva Systems Inc. $VEEV Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in Veeva Systems Inc. (NYSE:VEEV) by 4.0% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 142,913 shares of the technology company’s stock after acquiring an additional 5,496 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Veeva Systems were worth $42,575,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Citizens Business Bank acquired a new stake in Veeva Systems during the third quarter worth about $300,000. Intech Investment Management LLC grew its stake in shares of Veeva Systems by 37.8% in the 3rd quarter. Intech Investment Management LLC now owns 57,029 shares of the technology company’s stock valued at $16,990,000 after buying an additional 15,634 shares during the period. Fox Run Management L.L.C. acquired a new stake in shares of Veeva Systems during the 3rd quarter worth approximately $411,000. MAI Capital Management raised its position in shares of Veeva Systems by 193.6% during the 3rd quarter. MAI Capital Management now owns 3,444 shares of the technology company’s stock valued at $1,026,000 after buying an additional 2,271 shares during the period. Finally, Waddell & Associates LLC raised its position in shares of Veeva Systems by 90.3% during the 3rd quarter. Waddell & Associates LLC now owns 1,987 shares of the technology company’s stock valued at $592,000 after buying an additional 943 shares during the period. Institutional investors and hedge funds own 88.20% of the company’s stock.

Wall Street Analyst Weigh In

VEEV has been the subject of several analyst reports. BMO Capital Markets initiated coverage on Veeva Systems in a research report on Thursday, November 13th. They issued a “market perform” rating and a $300.00 price objective for the company. BTIG Research reiterated a “buy” rating and set a $340.00 price target on shares of Veeva Systems in a report on Friday, November 21st. Morgan Stanley upgraded shares of Veeva Systems from an “underweight” rating to an “equal weight” rating and reduced their price objective for the company from $222.00 to $205.00 in a report on Tuesday, February 17th. KeyCorp reaffirmed a “sector weight” rating on shares of Veeva Systems in a research report on Friday, December 12th. Finally, Weiss Ratings lowered shares of Veeva Systems from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 12th. Eighteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $293.71.

Veeva Systems Price Performance

Shares of Veeva Systems stock opened at $181.69 on Friday. The stock has a market capitalization of $29.87 billion, a price-to-earnings ratio of 35.35, a price-to-earnings-growth ratio of 1.26 and a beta of 1.08. The business has a 50-day moving average of $206.88 and a 200 day moving average of $250.34. Veeva Systems Inc. has a 12 month low of $168.13 and a 12 month high of $310.50.

Veeva Systems announced that its Board of Directors has initiated a stock repurchase plan on Monday, January 5th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the technology company to repurchase up to 5.5% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s management believes its shares are undervalued.

Insider Activity

In related news, insider Thomas D. Schwenger sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $231.43, for a total transaction of $231,430.00. Following the sale, the insider directly owned 23,204 shares of the company’s stock, valued at $5,370,101.72. This represents a 4.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 10.30% of the company’s stock.

Key Headlines Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva announced eSource, a product to streamline clinical-trial data capture and workflows — a strategic product that could accelerate adoption among pharma clients and support future subscription/solutions revenue growth. Veeva eSource launch
• Positive Sentiment: A broader software bounce after comments from Nvidia’s CEO easing AI cannibalization fears lifted enterprise software stocks, giving Veeva an intra-day boost as investors rotated back into high-quality SaaS names. Sector bounce after Nvidia comments
• Positive Sentiment: Investor attention has refocused on a recently approved ~$2B share buyback and upward estimate revisions ahead of the quarter — both factors that can support valuation and near-term shareholder returns. Valuation, buyback and estimate revisions
• Neutral Sentiment: Analysis pieces digging into Q4 (fiscal) metrics and Wall Street expectations provide detail that could amplify volatility around the upcoming earnings release — useful for investors but neutral until results arrive. Zacks Q4 projections
• Neutral Sentiment: Veeva is a trending search topic and several “what to know” roundups are circulating — they increase visibility but are informational rather than directional. Zacks trending stock note
• Negative Sentiment: Barclays issued a pessimistic forecast for Veeva, which is weighing on investor sentiment and can mechanically pressure the stock and investor expectations. Barclays bearish forecast
• Negative Sentiment: Stifel Nicolaus sharply cut its price target (from $320 to $212) while keeping a buy rating — the large reduction signals lower upside expectations and likely contributed to selling pressure. Stifel price-target cut
• Negative Sentiment: Oppenheimer trimmed its price target to $275, another analyst hit that reduces headline upside and can sap momentum ahead of earnings. Oppenheimer price-target cut
• Negative Sentiment: Short interest rose about 26% in early February to ~6.33M shares (4.3% of float), increasing the potential for downward pressure and volatility if bearish sentiment persists.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.